NIH Grants Biotech Firm Monopoly on Cutting-Edge Cancer Detection Tech
Published Date: 11/19/2025
Notice
Summary
The National Institutes of Health plans to give BioncoDx, LLC an exclusive license to use special methods for diagnosing and predicting cancer. This means BioncoDx will have the sole right to develop and sell these cancer-related technologies. If you want to comment or apply for a license, you need to act by December 4, 2025.
Analyzed Economic Effects
3 provisions identified: 1 benefits, 2 costs, 0 mixed.
Exclusive Urine-Based Cancer Test License
The NIH plans to grant BioncoDx, LLC an exclusive license to develop, manufacture, and commercialize Food and Drug Administration (FDA) premarket approval tests that use four urine biomarkers—creatine riboside, metabolite 561+, cortisol sulfate, and N-acetylneuraminic acid—to detect and prognose cancers (examples listed include lung, breast, colorectal, kidney/bladder, prostate, liver, stomach, pancreatic, GYN, and brain). The notice describes this technology as a unique, non-invasive screening and diagnostic tool that can detect cancers at an early stage using urine samples and that urine sampling minimizes patient discomfort compared with invasive methods.
Sole Commercial Rights for BioncoDx
The prospective license would give BioncoDx the sole (exclusive) right to practice the listed patent rights worldwide where patent rights exist for the specified field of use: developing, manufacturing, and commercializing FDA PMA tests using the named biomarkers for screening/diagnosing the listed cancers. After a negotiated period, the exclusive field of use will be reduced to a subset of three cancer indications and will include strict developmental benchmarks for each indication.
Prospective License Will Be Royalty‑Bearing
The notice states the prospective exclusive license will be royalty-bearing. The notice also states that the license may be granted unless, within fifteen (15) days from the date of the published notice, the National Cancer Institute receives written evidence and argument that the grant would not be consistent with applicable law.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-06501 — Government-Owned Inventions; Availability for Licensing
The National Institutes of Health is offering a cool new invention—special human antibodies that can fight certain cancers and autoimmune diseases—for companies to license and develop into treatments. This means businesses can jump on this opportunity to create powerful new medicines using government-backed research. Interested parties should act soon and may need to sign agreements to get full details.
2026-06283 — Prospective Grant of an Exclusive Patent License: Pigment Epithelium-Derived Factor (PEDF) Peptides and Use for Treating Retinal Degeneration
The National Eye Institute plans to give Perpetual Biosciences, Inc. an exclusive license to use special PEDF peptides to treat eye diseases that cause vision loss. This means the company will have the sole right to develop and sell this promising treatment, potentially helping millions with retinal degeneration. If you want to comment or apply for a license, act fast—submissions close April 16, 2026!
2026-05957 — Center for Scientific Review; Notice of Closed Meetings
The NIH’s Center for Scientific Review is holding several closed virtual meetings in April 2026 to review and decide on important research grant applications. These meetings affect scientists seeking funding in areas like neuroscience, cancer, and liver disease. No public access is allowed to protect private info and trade secrets, and these reviews help decide where millions in research money will go.
2026-05672 — National Institute on Deafness and Other Communication Disorders; Notice of Closed Meetings
The National Institute on Deafness and Other Communication Disorders is holding two closed meetings in late April and early May 2026 to review grant applications and evaluate researchers’ qualifications. These meetings affect scientists seeking funding and help ensure top-notch research gets supported. No public access means privacy is protected, and the process keeps the money flowing to the best projects on time.
2026-05673 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings on April 17, 2026, to review and evaluate important grant applications in health and science fields. These meetings protect private info and trade secrets while deciding who gets funding. Researchers and organizations applying for grants should note these dates as they impact funding decisions but don’t involve public attendance or extra costs.
2026-05738 — Submission for OMB Review; 30-Day Comment Request; National Institutes of Health (NIH) Loan Repayment Programs, (Office of the Director)
The NIH is asking for a 30-day public comment on extending its Loan Repayment Programs that help doctors and scientists pay off their student loans while they do important health research. This extension keeps the program running smoothly with no big changes, and comments are due by April 23, 2026. If you’re a researcher with student loans, this program could save you money while you help improve health!
Previous / Next Documents
Previous: 2025-20289 — Recertification of Cook Inlet Regional Citizens' Advisory Council
The Coast Guard has officially renewed the Cook Inlet Regional Citizens' Advisory Council (CIRCAC) for another year, from September 1, 2025, to August 31, 2026. This group keeps an eye on oil activities in Cook Inlet, Alaska, and since there were no big changes in their latest application, their recertification was smooth and quick. Local communities and environmental watchers can keep counting on CIRCAC’s watchful role without any new fees or delays.
Next: 2025-20291 — Agency Information Collection Activities: Comment Request on Burden Related to Superfund; Imported Substances; Procedures for Filing a Petition
The IRS wants your thoughts on how hard it is to ask if certain imported substances should be taxed or not under Superfund rules. This affects businesses dealing with these substances and could change how paperwork is handled, possibly saving time and money. Make sure to send your comments by January 20, 2026, to help shape the process!
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in